Semaglutide (Wegovy) for MASH.

The Medical letter on drugs and therapeutics2025PMID: 41060673

View on PubMed DOI: 10.58347/tml.2025.1739a

Keywords

MASHRezdiffraSaxendaWegovyZepboundadverse effectsdosageefficacyliraglutidemetabolic dysfunction-associated steatohepatitispioglitazoneresmetiromsafetysemaglutidetirzepatide